National Catastrophic Drug Insurance Revisited
Who Would Benefit from Senator Kirby's Recommendations
Bibliographic Data
| ID | 11967193 |
|---|---|
| Authors | Paul Grootendorst (0000-0003-1978-2834, McMaster University, corresponding author), Paul V Grootendorst, Michael R Veall (0009-0005-2800-1851, McMaster University) |
| Year | 2005 |
| Volume | 31 |
| Issue | 4 |
| Pages | 341-341 |
| Publication date | 2005-12-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Canadian Public Policy (JOURNAL) |
| Journal identifiers | ISSN: 0317-0861 • E-ISSN: 1911-9917 |
| Publisher | JSTOR (PUBLISHER) |
| DOI | 10.2307/3552355 |
| OpenAlex | W2237932322 |
| Language | EN |
| References cited | 2 |
Paul V. Grootendorst, Michael R. Veall, National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?, Canadian Public Policy / Analyse de Politiques, Vol. 31, No. 4 (Dec., 2005), pp. 341-358
Actuarial science · Business · Drug · Environmental health · Political science · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Healthcare Systems and Reforms · Medicine · Pharmacology
| Highly cited | No |
|---|